R L Koretz. Show Affiliations »
Abstract
Mesh： See more » Antiviral Agents/economicsAntiviral Agents/therapeutic useGastroenterology/economicsHepatitis C, Chronic/drug therapyHepatitis C, Chronic/economicsHumansInterferon alpha-2Interferon-alpha/economicsInterferon-alpha/therapeutic useRecombinant ProteinsRibavirin/economicsRibavirin/therapeutic use
Substances： See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsRibavirin
Year: 2000 PMID： 10833503 DOI： 10.1016/s0016-5085(00)70381-7
Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682